Glycopeptide-Resistance in Enterococci
- 21 June 2017
- book chapter
- Published by Springer Nature
- p. 289-305
Abstract
No abstract availableKeywords
This publication has 164 references indexed in Scilit:
- Staphylococcus aureus VRSA-11B Is a Constitutive Vancomycin-Resistant Mutant of Vancomycin-Dependent VRSA-11AAntimicrobial Agents and Chemotherapy, 2012
- The rise of the Enterococcus: beyond vancomycin resistanceNature Reviews Microbiology, 2012
- Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2010
- Inducible expression eliminates the fitness cost of vancomycin resistance in enterococciProceedings of the National Academy of Sciences, 2010
- VanA-Type Vancomycin-ResistantStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- VanA-Type Staphylococcus aureus Strain VRSA-7 Is Partially Dependent on Vancomycin for GrowthAntimicrobial Agents and Chemotherapy, 2009
- VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to VancomycinAntimicrobial Agents and Chemotherapy, 2009
- Molecular Characterization ofEnterococcus faecalisN06-0364 with Low-Level Vancomycin Resistance Harboring a Noveld-Ala-d-Ser Gene Cluster,vanLAntimicrobial Agents and Chemotherapy, 2008
- Synergism between β-Lactams and Glycopeptides against VanA-Type Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA OperonAntimicrobial Agents and Chemotherapy, 2006
- The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genomeNature Genetics, 2006